Kim Ozano:

Hello and welcome to the Connecting Citizens to Science Podcast.

Kim Ozano:

I'm Dr.

Kim Ozano:

Kim Ozano.

Kim Ozano:

This is a podcast about how communities and people join with researchers and scientists to

Kim Ozano:

Please don't forget to like rate share and subscribe so that we can continue to share voices from around the

Kim Ozano:

We hope you enjoy!

Kim:

Hello listeners and welcome to the Connecting Citizens to Science Podcast.

Kim:

We have a really important episode today.

Kim:

We are going to be talking about female genital schistosomiasis, which affects approximately 56

Kim:

I am here with co-host Pamela Mbabazi from the United Nations and guest Rhoda Ndubani, who is a study manager for a female

Kim:

Victoria Gamba, who is a gynaecologist based in Kenya.

Kim:

So let's start by saying hello to co-host Pamela.

Kim:

Hi Pamela.

Kim:

What is FGS?

Pamela:

The easiest way to describe it, it's a damage of the female genital tract that results from the deposition of tiny

Pamela:

This may sound like a big word, but more commonly people will know this as bilharzia, that's the easiest way to remember it.

Kim:

And how do women and girls come across the parasite?

Pamela:

The infection occur when women, girls, or even any individuals, uh, get in contact with infested water.

Pamela:

So you may be out, going for a swim and, um, in a fresh water body that's infected, you could be going to do your regular chores, washing

Pamela:

Just the fact that you have skin contact with an affected water body source where this parasite resides, it

Pamela:

And that's how you get the infection.

Pamela:

It is not a sexually transmitted infection despite the word, uh, female genital schistosomiasis, seeming to imply

Pamela:

It is not.

Pamela:

It's an infection that's acquired by getting in contact with infected water.

Kim:

I know that there's stigmatisation around FGS because of the area where the infection occurs.

Kim:

What is the impact of that stigmatisation, especially as often it's misdiagnosed as a sexually transmitted diseases.

Kim:

What's the impact for women in the areas where it's prevalent?

Pamela:

The main thing is that because of the anatomy that's affected, it's a private, intimate part of a human being.

Pamela:

This is an aspect of our human existence as females for which we are valued in most social cultural contexts, your reproductive potential

Pamela:

Stigma is a real issue.

Pamela:

Related to that, of course, is mental health and several other consequences that accompany that.

Kim:

Just to name a few of those consequences to set up the rest of the episode; I understand that it can

Kim:

Is that right?

Pamela:

That's absolutely right.

Pamela:

I'll use one explanation to show you how terrible this infection is when you have it.

Pamela:

Is that for every pair of worms that are circulating in your blood system, on average, each

Pamela:

Just imagine if you have like 200 worms, now multiply that by 500.

Pamela:

If you have 300 worms, a thousand worms, just keep the maths going and that equates into the equivalent of

Pamela:

Every day.

Pamela:

So just imagine what that would be like for you.

Pamela:

It's a terrible, terrible condition to have.

Kim:

Yeah, I think that analogy's really important to understand the severity and also to recognise that it's

Kim:

Thank you for highlighting that.

Kim:

But the good news is there is global action on FGS, and we have three great guests with us today, which I'm gonna

Pamela:

Victoria, what do you know about FGS in the course of your work and how has this changed your own practice?

Victoria:

Very good question.

Victoria:

I'm an obstetrician and gynecologist practicing in Nairobi, Kenya.

Victoria:

First and foremost, we knew about neuro genital schistosomiasis, all the way from undergraduate studies.

Victoria:

However, the genital aspect has been very silent in most of the textbooks.

Victoria:

You don't get to see exactly how it looks like.

Victoria:

And even as we continued just doing our usual screening tests or speculum examination, the only thing we knew how

Victoria:

If you don't know what it is, as long as it's not on the bad end of the spectrum, you allow the women to go home.

Victoria:

At that point we still didn't know exactly how FGS presents or looks like during speculum examination, but then through our

Victoria:

I think now it has influenced our practice to be more aware about how FGS looks like, whenever you're doing any screening

Pamela:

Clearly you as a professional have had to address some misconceptions about, the disease.

Pamela:

As you said, uh, basically a low clinical index of suspicion, which in the course of your work, you also

Pamela:

Rhoda, what type of innovations, do you think, uh, could be done or are necessary to be able to overcome the type of

Rhoda:

There's a lot of challenge to diagnose FGS in most of our health facilities due to limited resources and of course equipment.

Rhoda:

I must say, in one of studies we did on FGS, one of the things that we actually did identify was the

Rhoda:

FGS is not something that is routinely tested in the health facility.

Rhoda:

So if a woman presents those symptoms, the first test that will be given is either on sexually transmitted infections or UTI.

Rhoda:

So already there is that barrier and also chances of being misdiagnosed.

Rhoda:

Also resources are also lacking in these public health facilities.

Rhoda:

So there's need for more resources and also more equipments that could help diagnose FGS at the moment in most of the health

Pamela:

How can science and research make sure that we bridge this knowledge gap such that a woman is able to get a diagnosis

Rhoda:

I think one of the things we could do to improve on that is of course, provide the women

Rhoda:

First of all to find out how can they get the parasite, what can they do to prevent getting the parasite?

Rhoda:

And also where can they go to seek health services if they have FGS.

Rhoda:

I think it's impacting that knowledge amongst community members that will help us in the long run to fight FGS.

Rhoda:

Once the community's aware about it, they know how to prevent FGS, or they know where they can seek services for FGS, I think

Pamela:

One can't help but think of self-testing as well as a possible option.

Pamela:

The testing for Covid-19 was quite rigorous, but now it's the diagnostics and research has moved to

Pamela:

Do you see that becoming a possibility in the future?

Rhoda:

In the studies that I've worked on, in the study that I'm currently working on, we are using the

Rhoda:

This is done in the community at household level as well as the health facility.

Rhoda:

When we go in the households to provide the self sampling tests, you have to, first of all give the women the knowledge on FGS

Rhoda:

We've noticed in the study is that there's high acceptability of the self-test, which is very positive.

Rhoda:

Of course there could be challenges with, uh, providing these self-test kits, the costs, those, um, limited resources, I

Pamela:

We hope to see that something like that actually comes into reality.

Pamela:

And then you can look back to us, to WHO, to work with our partners and figure out how to look for subsidies and work with governments

Pamela:

Victoria, which innovative ways do you see us trying to actually get the gynecologists in our type of settings to engage more on FGS?

Victoria:

The most important thing at this point is to remember you're dealing with women.

Victoria:

So when you use a human-centered approach or a human lens, when you look at that woman, she carries a lot of things.

Victoria:

She might have a breast disease, she might have uterine disease, she might have all this.

Victoria:

And I want to thank all the stakeholders that have put forward, you know, different programmes that are bit siloed at the moment,

Victoria:

For sure that woman won't come back.

Victoria:

So to ensure that continuity is there, I think number one is, leveraging on the existing programmes that are available...

Pamela:

mm-hmm.

Victoria:

...and just looking for ways where we can integrate things because I mean, um, you're a woman, going

Pamela:

mm-hmm.

Victoria:

...so you can imagine having to do like different speculum examination for each clinician that you see.

Victoria:

So if there's any way that we can be able to have the integrated algorithm, or this is how FGS looks like; if you're screening

Victoria:

Basically it's more about calls for integration and being accountable to these women.

Victoria:

I think, uh, we ought to give them what they deserve.

Pamela:

Indeed.

Pamela:

You have highlighted several ways in which possibly there are latent opportunities that we are underutilising,

Pamela:

And indeed, WHO put aside some guidelines of how this could be done over the life course.

Pamela:

We need to be centered on the woman as a whole, not, not an anatomy or a disease per se.

Pamela:

So from Christine would like to hear, what would be your suggestions from the perspective of a community social scientist; how do you see

Christine:

Young girls are in a community, so the idea of this podcast being about reaching communities is important

Christine:

In most cases, the young girls are either under older women or under men; husbands or fathers or uncles.

Christine:

There is something important reaching out to the whole community as one, letting the information go further than just the

Christine:

So I think there's a lot about sensitisation on a large community at once, not just targeting young

Pamela:

Again, we know that knowledge is power.

Pamela:

We need to empower women.

Pamela:

We need to empower girls, not only to strengthen the agency that they already have themselves, but also to be stronger placed to

Pamela:

So what are some of the ways you see this being done in a manner that's sustainable and effective in the

Rhoda:

We use drama performances to raise awareness about FGS in the community amongst the girls and women and also to inform women

Rhoda:

We did train a drama group in the community, the drama group went and performed drama scripts relating to FGS.

Rhoda:

We did get quite a good response from the women, um, after they learnt more about FGS through the drama.

Rhoda:

And I must say that during the drama performance, you could see women, um, asking more questions.

Rhoda:

When we talked about the symptoms for FGS, they became very attentive and asked a lot of questions about that.

Rhoda:

Later on they would actually accept to go and be tested for FGS.

Rhoda:

I must say that, um, you know, as we raise this awareness, as we give this knowledge about FGS to

Rhoda:

Looking at our African context, there are times where a woman needs to get permission from their spouses, to go and have some of these tests.

Rhoda:

So as we did the drama, we also, uh, tried to invite the men's also to come for these, uh, performances

Rhoda:

We also engaged quite a number of community leaders, which I think is also very important as you

Rhoda:

It's also good to engage the community leaders.

Rhoda:

The men were also invited.

Rhoda:

During these drama performances, we also produced brochures...

Pamela:

mm-hmm,

Rhoda:

...uh, that had more information about FGS, which we gave out to the men, but also even the women, they also asked for

Rhoda:

I would say it's very important to bring in all these strategies.

Pamela:

Thank you so much once again, Rhoda, for highlighting the intersectionality with several other things that

Pamela:

While we address these issues, we know that um, we really need our males to also step up and be part of this.

Pamela:

We know that to address FGS, we also need the agency and participation of males.

Christine:

There is the issue around power and gender decision making is mostly in the hands of men, in most of the cultures, for

Christine:

This is something the men have more of a monopoly on.

Christine:

I think there is the gender dynamics and there are also other things that play a huge role there, but empowering

Pamela:

Thank you so much for all your insights.

Kim:

Thanks Pamela.

Kim:

That was a wonderful conversation.

Kim:

Rhoda.

Kim:

Could you give us one piece of advice for those working in FGS and trying to reach communities.

Rhoda:

It's very important to engage communities as we do research.

Rhoda:

One of the things is bringing on board, uh, the different community stakeholders within the community.

Rhoda:

As you start your project, make sure that the community leaders, uh, community-based organisations are involved at the beginning of the

Rhoda:

It is also important to make sure that you give out more information, the right information about your research to

Rhoda:

At the end of the day, uh, it's what gives you the positive response and the best results for your research.

Kim:

Victoria, please, one piece of advice for others in your position.

Victoria:

One of the things that I do want to bring out is, as Rhoda has said, it's mostly about engaging all stakeholders

Victoria:

It brings about continuity.

Victoria:

It allows you to penetrate further into the communities.

Victoria:

And at the end of the day, you also have to listen.

Victoria:

I know we do come up with, um, approaches that are textbook, but you also have to listen, look,

Victoria:

What are their challenges?

Victoria:

Why are they doing certain activities so that, you know, you bring about an intervention that can work and it's

Kim:

Great.

Kim:

So generate that demand and make sure that the programmes are sustainable long-term.

Kim:

Wonderful.

Kim:

Mm-hmm.

Kim:

and Christine, one piece of advice, please.

Christine:

The first thing is to encourage anybody wanting to work in communities, to reach out to communities, because

Christine:

This means meeting the people themselves, working with their social structures, engaging with them at once.

Christine:

The idea of ownership is something which is key for us in social science because I won't just come

Christine:

You have the traditional health workers, you have the traditional birth attendance.

Christine:

These are ladies who know the communities, they know the people.

Christine:

Once you meet these women and explain what you want to do, that's already a huge step in getting access to other women.

Christine:

So there's a whole mechanism, which is based within communities and just a bit of understanding, stakeholder mapping around these

Kim:

And finally, to take us home.

Kim:

Pamela, what piece of advice would you like to end the show on?

Pamela:

I would like to point out that uh, the WHO member states have endorsed a roadmap for addressing

Pamela:

In this we have a goal to eliminate morbidity due to schistosomiasis and female genital schistosomiasis is one of them.

Pamela:

This goal is very well aligned also with the intention to eliminate cervical cancer by the year 2070 so it'll be a shame

Pamela:

I would call on everyone to familiarise themself with the strategic document that's been put out and the

Pamela:

Preventive, chemotherapy, treat, treat, treat, treat.

Pamela:

Treat people with Praziquantel.

Pamela:

Don't wait for diagnosis.

Pamela:

Treat upon suspicion.

Pamela:

Treat water and sanitation.

Pamela:

We need to give people better water, and most importantly also for those that have established morbidity, we really

Kim:

Thank you Pamela.

Kim:

Wonderful pieces of information there for, for the audience to act on and, um, some calls to action as well.

Kim:

So thank you to all of our guests today and the wonderful co-host, Pamela, thank you for your participation.

Kim:

And to our audience and our listeners, please don't forget to like, rate, share, and subscribe so we can continue to bring the

Kim:

Thank you very much, and bye for now.

Kim:

Bye everyone.

Rhoda:

Bye.

Rhoda:

Thank you so much.

Rhoda:

Bye-bye.